Search research articles
Contact Us
Filters
Showing results (11-20 of 206) with videos related to
Page
of 21
Sort By:
Paediatric Drugs
|
April 5, 2007
Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis
Sanjiv Sharma, Adam Jaffe, Garth Dixon
Paediatric Drugs
|
June 1, 2002
Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids
Adam Jaffe, Ian M Balfour-Lynn
Journal of Paediatrics and Child Health
|
October 15, 2016
Persistent growth effects of inhaled corticosteroids
Mon Ohn, Adam Jaffe, Hiran Selvadurai
Respirology (Carlton, Vic.)
|
May 17, 2014
Cannabis smoking and respiratory health: consideration of the literature
Peter Gates, Adam Jaffe, Jan Copeland
The Lancet. Child & Adolescent Health
|
June 23, 2019
Children's interstitial and diffuse lung disease
Steve Cunningham, Adam Jaffe, Lisa R Young
Plos One
|
August 13, 2019
The procurement of innovation by the U.S. government
Gaétan de Rassenfosse, Adam Jaffe, Emilio Raiteri
Journal of Paediatrics and Child Health
|
December 1, 2009
Call for a national plan for rare diseases
Adam Jaffe, Yvonne Zurynski, Lyndall Beville, et al.
Respiratory Medicine
|
November 4, 2024
Understanding the acceptability of the changing model of care in cystic fibrosis
Michael Doumit, Verity Pacey, Adam Jaffe, et al.
The Medical Journal of Australia
|
September 23, 2008
Consent in paediatric research: an evaluation of the guidance provided in the 2007 NHMRC National statement on ethical conduct in human research
Adam Jaffe, Roxanne E Strachan, Katrina J Williams
Journal of Paediatrics and Child Health
|
April 16, 2021
Rare diseases research and policy in Australia: On the journey to equitable care
Kaustuv Bhattacharya, Nicole Millis, Adam Jaffe, et al.
Page
of 21
Search research articles
Search
Showing results (11-20 of 206) with videos related to
Sort By:
Page
of 21
Paediatric Drugs
|
April 5, 2007
Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis
Sanjiv Sharma, Adam Jaffe, Garth Dixon
Paediatric Drugs
|
June 1, 2002
Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids
Adam Jaffe, Ian M Balfour-Lynn
Journal of Paediatrics and Child Health
|
October 15, 2016
Persistent growth effects of inhaled corticosteroids
Mon Ohn, Adam Jaffe, Hiran Selvadurai
Respirology (Carlton, Vic.)
|
May 17, 2014
Cannabis smoking and respiratory health: consideration of the literature
Peter Gates, Adam Jaffe, Jan Copeland
The Lancet. Child & Adolescent Health
|
June 23, 2019
Children's interstitial and diffuse lung disease
Steve Cunningham, Adam Jaffe, Lisa R Young
Plos One
|
August 13, 2019
The procurement of innovation by the U.S. government
Gaétan de Rassenfosse, Adam Jaffe, Emilio Raiteri
Journal of Paediatrics and Child Health
|
December 1, 2009
Call for a national plan for rare diseases
Adam Jaffe, Yvonne Zurynski, Lyndall Beville, et al.
Respiratory Medicine
|
November 4, 2024
Understanding the acceptability of the changing model of care in cystic fibrosis
Michael Doumit, Verity Pacey, Adam Jaffe, et al.
The Medical Journal of Australia
|
September 23, 2008
Consent in paediatric research: an evaluation of the guidance provided in the 2007 NHMRC National statement on ethical conduct in human research
Adam Jaffe, Roxanne E Strachan, Katrina J Williams
Journal of Paediatrics and Child Health
|
April 16, 2021
Rare diseases research and policy in Australia: On the journey to equitable care
Kaustuv Bhattacharya, Nicole Millis, Adam Jaffe, et al.
Page
of 21